DNA RNA and Cells
23 January 2014
California Stem Cell Submits Phase II Clinical Trial Protocol to FDA for Treating Ovarian Cancer23 January 2014
Inovio Pharmaceuticals Unveils Potent New Immune Activator22 January 2014
ATL1102 for Stem Cell Mobilisation Trial Approval21 January 2014
Pluristem’s Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints16 January 2014
Cytonet Submits European Approval Application For Liver Cell Therapy To Treat Urea Cycle Disorders In Children14 January 2014
Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness14 January 2014
Rexahn Initiates Phase IIa Clinical Trial of Archexin® in Patients with Metastatic Renal Cell Carcinoma13 January 2014
Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program13 January 2014
BioMarin Announces Selection of Factor VIII Gene Therapy Drug Development Candidate BMN 270 for the Treatment of Hemophilia A9 January 2014
Cardio3 BioSciences Receives IND Clearance from the FDA for its CHART-2 Phase III Heart Failure Clinical Trial8 January 2014
Target Enrollment Achieved in CAVATAK™ USA Phase 2 Melanoma Trial with Excellent Interim Results19 December 2013
Athersys Confirms Completion of Patient Enrollment of Pfizer’s Phase II Study of MultiStem(R) Cell Therapy for Ulcerative Colitis17 December 2013
Capricor Therapeutics Cleared to Begin Phase II Portion of ALLSTAR Clinical Trial with CAP-1002 in Patients Following Heart Attack16 December 2013
OncoSec Medical Announces Positive Interim Data from Phase 2 Study of OMS-I100 in Metastatic MelanomNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports